Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term

NCT04003922 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT04003922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04003922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long Term
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Observational
Overall status
Unknown status
Start date
April 21, 2020
Completion date
October 31, 2025
Enrollment
40 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

rasmussen encephalitis